EE200100153A - Kontrollitav ravimiväljutussüsteem ravimite suukaudseks manustamiseks, mis pakub ajalist ja ruumilist kontrolli - Google Patents

Kontrollitav ravimiväljutussüsteem ravimite suukaudseks manustamiseks, mis pakub ajalist ja ruumilist kontrolli

Info

Publication number
EE200100153A
EE200100153A EEP200100153A EEP200100153A EE200100153A EE 200100153 A EE200100153 A EE 200100153A EE P200100153 A EEP200100153 A EE P200100153A EE P200100153 A EEP200100153 A EE P200100153A EE 200100153 A EE200100153 A EE 200100153A
Authority
EE
Estonia
Prior art keywords
drug delivery
spatial control
delivery system
provides temporal
oral
Prior art date
Application number
EEP200100153A
Other languages
English (en)
Estonian (et)
Inventor
Talwar Naresh
Sen Himadri
H. Staniforth John
Original Assignee
Ranbaxy Laboratories Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/152,932 external-priority patent/US6261601B1/en
Application filed by Ranbaxy Laboratories Limited filed Critical Ranbaxy Laboratories Limited
Publication of EE200100153A publication Critical patent/EE200100153A/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0065Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/06Antigout agents, e.g. antihyperuricemic or uricosuric agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Virology (AREA)
  • Nutrition Science (AREA)
  • Transplantation (AREA)
  • Cardiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pulmonology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Child & Adolescent Psychology (AREA)
  • Physiology (AREA)
  • Epidemiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
EEP200100153A 1998-09-14 1999-01-19 Kontrollitav ravimiväljutussüsteem ravimite suukaudseks manustamiseks, mis pakub ajalist ja ruumilist kontrolli EE200100153A (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/152,932 US6261601B1 (en) 1997-09-19 1998-09-14 Orally administered controlled drug delivery system providing temporal and spatial control
PCT/IB1999/000078 WO2000015198A1 (en) 1998-09-14 1999-01-19 Orally administered controlled drug delivery system providing temporal and spatial control

Publications (1)

Publication Number Publication Date
EE200100153A true EE200100153A (et) 2002-06-17

Family

ID=22545063

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200100153A EE200100153A (et) 1998-09-14 1999-01-19 Kontrollitav ravimiväljutussüsteem ravimite suukaudseks manustamiseks, mis pakub ajalist ja ruumilist kontrolli

Country Status (41)

Country Link
EP (2) EP1107741B1 (ru)
JP (1) JP2002524494A (ru)
CN (1) CN1186013C (ru)
AP (1) AP1659A (ru)
AR (1) AR022672A1 (ru)
AT (1) ATE245414T1 (ru)
AU (1) AU758324B2 (ru)
BG (1) BG105339A (ru)
BR (1) BR9913696A (ru)
CA (1) CA2343760A1 (ru)
CO (1) CO5130022A1 (ru)
CU (1) CU23040A3 (ru)
CZ (1) CZ2001901A3 (ru)
DE (1) DE69909801T2 (ru)
DK (1) DK1107741T3 (ru)
EA (2) EA004443B1 (ru)
EE (1) EE200100153A (ru)
ES (1) ES2204098T3 (ru)
GE (1) GEP20043216B (ru)
HK (1) HK1037967A1 (ru)
HR (1) HRP20010187B1 (ru)
HU (1) HUP0103632A3 (ru)
ID (1) ID29843A (ru)
IL (1) IL141977A0 (ru)
IS (1) IS5885A (ru)
MX (1) MXPA01002634A (ru)
MY (1) MY127952A (ru)
NO (1) NO20011276L (ru)
NZ (2) NZ510487A (ru)
OA (1) OA11652A (ru)
PE (1) PE20001058A1 (ru)
PL (1) PL346798A1 (ru)
PT (1) PT1107741E (ru)
SI (1) SI1107741T1 (ru)
SK (1) SK285478B6 (ru)
SV (1) SV1999000152A (ru)
TR (1) TR200100731T2 (ru)
UA (1) UA73287C2 (ru)
UY (1) UY25710A1 (ru)
WO (1) WO2000015198A1 (ru)
ZA (1) ZA995839B (ru)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2400950A1 (en) * 2000-03-03 2001-09-07 Ranbaxy Laboratories Limited Orally administered controlled delivery system for once daily administration of ciprofloxacin
DE10031043A1 (de) 2000-06-26 2002-02-14 Bayer Ag Retardzubereitungen von Chinolonantibiotika und Verfahren zu ihrer Herstellung
AU2006202275A1 (en) * 2000-06-26 2006-06-22 Bayer Healthcare Ag Sustained-release preparations of quinolone antibiotics and method for preparation thereof
JP3573287B2 (ja) 2000-08-08 2004-10-06 第一製薬株式会社 高吸収性固形製剤
IN192748B (ru) * 2000-08-29 2004-05-15 Ranbaxy Lab Ltd
EP1347748A2 (en) 2000-12-05 2003-10-01 MacGregor, Alexander Hydrostatic delivery system for controlled delivery of agent
WO2003011255A1 (en) 2001-07-04 2003-02-13 Sun Pharmaceutical Industries Limited Gastric retention controlled drug delivery system
NZ531461A (en) * 2001-08-16 2008-03-28 Oregon State Expandable gastric retention device
WO2003017981A1 (en) * 2001-08-29 2003-03-06 Ranbaxy Laboratories Limited Controlled release formulation of clarithromycin or tinidazol
EP1439820A2 (en) * 2001-10-29 2004-07-28 Labopharm Inc. Methods and dosage forms for improving the bioavailability of therapeutic agents
MXPA04004544A (es) * 2001-11-13 2005-03-31 Yamanouchi Pharma Tech Inc Sistema de liberacion prolongada para droga soluble.
DE60117712T2 (de) 2001-11-19 2006-11-16 Lupin Ltd., Mumbai Pharmazeutische zusammensetzung für die kontrollierte freisetzung eines beta-lactam-antibiotikums
CZ20041117A3 (cs) * 2002-04-23 2005-04-13 Lupin Limited Dlouhodobě působící kompozice zahrnující zidovudin a lamivudin
WO2005018613A1 (de) * 2003-08-26 2005-03-03 Mandapro Ag Pellets für die orale applikation von pharmazeutischen wirkstoffen
DE102004042139B4 (de) * 2004-08-31 2009-06-10 Aristocon Verwaltungs- Gmbh Perorale Darreichungsformen zur Erzielung eines Retardierungseffektes nach der Arzneimitteleinnahme mit einer Mahlzeit
GB0501810D0 (en) * 2005-01-28 2005-03-09 Pharmakodex Ltd Chemotherapeutic formulations
US20090099154A1 (en) * 2005-06-29 2009-04-16 Panacea Biotec Ltd. Pharmaceutical Sustained Release Compositions and Processes Thereof
ATE396710T1 (de) * 2005-07-19 2008-06-15 Ethypharm Sa Gastroretentive zusammensetzungen und verfahren zur herstellung
GB0515492D0 (en) * 2005-07-28 2005-08-31 Reckitt Benckiser Healthcare Improvements in or relating to compositions,articles and methods
KR20080076382A (ko) * 2007-02-15 2008-08-20 (주)아모레퍼시픽 실로스타졸의 제어방출 제제 및 그 제조방법
ZA200903854B (en) * 2008-06-19 2011-02-23 Univ Of The Witwatesrand Johannesburg A gastroretentive pharmaceutical dosage form
KR20110042366A (ko) 2008-08-18 2011-04-26 팀 아카데미 오브 파마슈티컬 사이언스 위장체류 약물 전달 시스템, 제작 방법 및 그것들의 사용
WO2011125075A2 (en) 2010-04-08 2011-10-13 Fdc Limited A novel gastroretentive delivery of macrolide
EP2415460A1 (de) * 2010-08-03 2012-02-08 ratiopharm GmbH Orale Darreichungsform von Pregabalin
TWI705814B (zh) * 2014-06-20 2020-10-01 美商梅琳塔有限責任公司 醫藥組成物及其用途
CN106999429B (zh) 2014-11-19 2020-09-18 杜邦营养美国有限公司 纳米悬浮剂制剂
US10987311B2 (en) 2017-06-16 2021-04-27 Kashiv Specialty Pharmaceuticals, Llc Extended release compositions comprising pyridostigmine
US10918597B2 (en) 2017-06-16 2021-02-16 Kashiv Specialty Pharmaceuticals, Llc Gastroretentive dosage forms for sustained drug delivery
US10588863B2 (en) 2017-06-16 2020-03-17 Kashiv Biosciences, Llc Extended release compositions comprising pyridostigmine
EP3609472B1 (en) 2018-06-18 2020-12-30 Kashiv Specialty Pharmaceuticals, LLC Extended release compositions comprising pyridostigmine
JP7034343B2 (ja) 2018-06-27 2022-03-11 アムニール コンプレックス プロダクツ リサーチ エルエルシー 自己調節性の浸透性胃保持性薬物送達システム
CN110448535A (zh) * 2019-09-04 2019-11-15 湖南宇山玉月农业科技有限公司 一种裂褶菌素胃漂浮片
CN111116794A (zh) * 2019-12-20 2020-05-08 蚌埠市鑫晟新材料科技有限公司 一种中性造纸用聚合材料的制备方法
CN115715765A (zh) * 2021-08-24 2023-02-28 江苏万邦生化医药集团有限责任公司 一种悬浮片剂
CN113768898A (zh) * 2021-09-14 2021-12-10 江苏万邦生化医药集团有限责任公司 悬浮的胶囊片

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0798742B2 (ja) * 1986-07-03 1995-10-25 ゼリア新薬工業株式会社 徐放性製剤組成物
US5096714A (en) * 1988-06-28 1992-03-17 Hauser-Kuhrts, Inc. Prolonged release drug tablet formulations
JPH0624959A (ja) * 1991-10-04 1994-02-01 Bayer Yakuhin Kk 胃内浮遊型薬物徐放性固形製剤

Also Published As

Publication number Publication date
NO20011276D0 (no) 2001-03-13
DE69909801D1 (de) 2003-08-28
NZ510487A (en) 2003-04-29
BR9913696A (pt) 2001-10-09
UA73287C2 (en) 2005-07-15
ZA995839B (en) 2000-03-28
ATE245414T1 (de) 2003-08-15
AR022672A1 (es) 2002-09-04
IS5885A (is) 2001-03-12
HRP20010187A2 (en) 2002-04-30
AU758324B2 (en) 2003-03-20
MY127952A (en) 2007-01-31
GEP20043216B (en) 2004-04-26
EP1281397A1 (en) 2003-02-05
OA11652A (en) 2004-12-08
SV1999000152A (es) 2000-07-03
NZ523747A (en) 2004-04-30
AU1779499A (en) 2000-04-03
JP2002524494A (ja) 2002-08-06
ES2204098T3 (es) 2004-04-16
CN1325299A (zh) 2001-12-05
PT1107741E (pt) 2003-12-31
CN1186013C (zh) 2005-01-26
HRP20010187B1 (en) 2004-04-30
SK3472001A3 (en) 2001-10-08
HUP0103632A2 (hu) 2002-02-28
EP1107741A1 (en) 2001-06-20
DE69909801T2 (de) 2004-06-03
HK1037967A1 (en) 2002-03-01
NO20011276L (no) 2001-05-10
SK285478B6 (sk) 2007-02-01
CA2343760A1 (en) 2000-03-23
EP1107741B1 (en) 2003-07-23
CZ2001901A3 (cs) 2001-08-15
WO2000015198A1 (en) 2000-03-23
EA200100346A1 (ru) 2001-10-22
CO5130022A1 (es) 2002-02-27
BG105339A (en) 2001-11-30
EA200300847A1 (ru) 2003-12-25
SI1107741T1 (en) 2004-02-29
UY25710A1 (es) 2000-03-31
DK1107741T3 (da) 2003-11-17
EA005767B1 (ru) 2005-06-30
TR200100731T2 (tr) 2001-06-21
AP1659A (en) 2006-09-06
PE20001058A1 (es) 2000-10-05
AP2001002098A0 (en) 2001-03-31
ID29843A (id) 2001-10-18
IL141977A0 (en) 2002-03-10
MXPA01002634A (es) 2002-06-04
HUP0103632A3 (en) 2005-06-28
PL346798A1 (en) 2002-02-25
CU23040A3 (es) 2005-04-14
EA004443B1 (ru) 2004-04-29

Similar Documents

Publication Publication Date Title
EE200100153A (et) Kontrollitav ravimiväljutussüsteem ravimite suukaudseks manustamiseks, mis pakub ajalist ja ruumilist kontrolli
NO994837L (no) Intravesikal medikamentavleveringssystem
PL325774A1 (en) Drug delivery system for two or more active substances
EE200000546A (et) Aerosoolistatud toimeaine manustamissüsteem
EE200100293A (et) Kontrollitud vabanemisega ravivorm, mis sisaldab GnRH-II
DK1034008T3 (da) Dosisindstillende indretning til medicinske injektorer
BR9804500B1 (pt) derivado de amida, referida composição farmacêutica e agente terapêutico.
EP1229962A4 (en) LASER SYSTEM FOR ENHANCED DELIVERY OF THERAPEUTIC RADIATION THROUGH A BARRIER
NO20004196D0 (no) Innretninger for legemiddelavlevering
ZA200107123B (en) Oral drug delivery system.
ID28232A (id) Formulasi farmasi dengan pelepasan terkontrol
IL159875A0 (en) Zero order controlled drug delivery system
ZA97976B (en) Uniform drug delivery theraphy.
EP0989878A4 (en) DRUG DELIVERY SYSTEM
EP1021137A4 (en) ARRANGEMENT FOR MEDICINE DELIVERY
ZA200007111B (en) Methods and devices for providing prolonged drug therapy.
DK0984774T3 (da) Mikrosfærer med gastroretentivt reguleret frigivelse til forbedret lægemiddelafgivelse
DK1183061T3 (da) Lægemiddelafgivelsessystem
GB9923273D0 (en) Medicament delivery system
GB9905134D0 (en) Medicament delivery system
GB9917470D0 (en) Medicament delivery system
GB9902509D0 (en) Drug delivery system
GB9901133D0 (en) Drug delivery system
GB9700355D0 (en) Drug delivery system
GB0108136D0 (en) Respiratory system drug applicator